GB1322640A - Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon - Google Patents

Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon

Info

Publication number
GB1322640A
GB1322640A GB5089371A GB5089371A GB1322640A GB 1322640 A GB1322640 A GB 1322640A GB 5089371 A GB5089371 A GB 5089371A GB 5089371 A GB5089371 A GB 5089371A GB 1322640 A GB1322640 A GB 1322640A
Authority
GB
United Kingdom
Prior art keywords
methyl
phenylalkyl
substituted
method based
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5089371A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kendall Co
Original Assignee
Kendall Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kendall Co filed Critical Kendall Co
Publication of GB1322640A publication Critical patent/GB1322640A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Making Paper Articles (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

1322640 Analgesic medicines KENDALL CO 2 Nov 1971 [9 Nov 1970] 50893/71 Heading A5B [Also in Divisions C2 and C3] Pharmaceutical compositions in conventional forms for oral or parenteral administration and having analgesic activity comprise a compound of formula wherein m is 1 or 2; R 1 and R 2 independently represent hydrogen, methyl or ethyl, with the provisos that the radical -(-CR 1 R 2 -)- m contains not more than one ethyl group or more than two methyl groups, that when m is 1 said radical contains at least one hydrogen and that when m is 2 said radical contains at least two hydrogens; R 3 and R 4 independently represent hydrogen or methyl, or R 3 and R 4 are both methoxymethyl or are both acetoxymethyl; X is hydrogen, chlorine, -NO 2 or methoxy; and Z is -O-R<SP>1</SP> or -O-C-R<SP>1</SP> wherein R<SP>1</SP> is an alkyl radical containing 1 to 3 carbon atoms, or -OSi(R") 3 wherein R" is methyl or ethyl, and a physiologically acceptable carrier therefore.
GB5089371A 1970-11-09 1971-11-02 Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon Expired GB1322640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8819370A 1970-11-09 1970-11-09

Publications (1)

Publication Number Publication Date
GB1322640A true GB1322640A (en) 1973-07-11

Family

ID=22209926

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5089371A Expired GB1322640A (en) 1970-11-09 1971-11-02 Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon

Country Status (16)

Country Link
JP (1) JPS554099B1 (en)
AR (2) AR194578A1 (en)
AT (1) AT321937B (en)
AU (1) AU462551B2 (en)
BE (1) BE775117A (en)
CH (1) CH568987A5 (en)
DE (1) DE2155469C2 (en)
DK (1) DK135283B (en)
ES (1) ES396825A1 (en)
FR (1) FR2112555B1 (en)
GB (1) GB1322640A (en)
IL (1) IL38094A (en)
LU (1) LU64226A1 (en)
NL (1) NL174042C (en)
NO (1) NO133497C (en)
SE (1) SE385887B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000026259A1 (en) * 1998-11-04 2000-05-11 Montell Technology Company Bv Components and catalysts for the polymerization of olefins

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894023A (en) * 1973-07-12 1975-07-08 Kendall & Co 5-Pivaloyloxy-5-(1-phenylethyl) barbituric acid
IT1196500B (en) * 1986-07-16 1988-11-16 Eniricerche Spa MALONIC ACID DERIVATIVES AND METHODS FOR THEIR SYNTHESIS

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000026259A1 (en) * 1998-11-04 2000-05-11 Montell Technology Company Bv Components and catalysts for the polymerization of olefins
US6605562B1 (en) 1998-11-04 2003-08-12 Basell Poliolefine Italia S.P.A. Components and catalysts for the polymerization of olefins
US6689850B2 (en) 1998-11-04 2004-02-10 Basell Poliolefine Italia S.P.A. Process for the polymerization of olefins
US6699814B2 (en) 1998-11-04 2004-03-02 Basell Poliolefine Italia S.P.A. Catalysts for the polymerization of olefins

Also Published As

Publication number Publication date
DE2155469C2 (en) 1984-08-23
NO133497B (en) 1976-02-02
BE775117A (en) 1972-03-01
DE2155469A1 (en) 1972-05-10
ES396825A1 (en) 1974-06-16
SE385887B (en) 1976-07-26
DK135283C (en) 1977-09-05
IL38094A (en) 1975-11-25
AR194578A1 (en) 1973-07-31
NO133497C (en) 1976-05-12
AR194697A1 (en) 1973-07-31
FR2112555A1 (en) 1972-06-16
IL38094A0 (en) 1972-01-27
AU462551B2 (en) 1975-06-26
AU3549471A (en) 1973-05-17
NL7115404A (en) 1972-05-12
FR2112555B1 (en) 1975-12-26
NL174042C (en) 1984-04-16
AT321937B (en) 1975-04-25
NL174042B (en) 1983-11-16
DK135283B (en) 1977-03-28
LU64226A1 (en) 1972-05-29
CH568987A5 (en) 1975-11-14
JPS554099B1 (en) 1980-01-29

Similar Documents

Publication Publication Date Title
ATE36699T1 (en) QUINONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL COMPOSITION.
MY100343A (en) Amide derivative and external medicament comprising same
GB1505305A (en) Benzcycloamide derivatives
GB1331405A (en) Esters their production and their medicinal use
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
GB940596A (en) ª -hydrazino acids
GB1260848A (en) Propanolamine derivatives
GB1392275A (en) Therapeutic compositions
GB1374367A (en) Propionamide derivative a method of making it and therapeutic compositions containing it
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
GB1342520A (en) Alpha-alkyl-substituted benzyl or thenyl-benzyloxy derivatives of amines
GB1439724A (en) Berbine derivatives and pharmaceutical compositions containing them
GB1479297A (en) 4-substituted butan-2-ones but-3-en-2-ones butan-2-ols and but-3-en-2-ols and pharmaceutical compositions containing them
GB1322640A (en) Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon
GB1444396A (en) Succinic acid derivatives
GB1158279A (en) Carbocyclic Ferrocenes
GB1293507A (en) Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparation
GB1378068A (en) Citric acid derivatives
GB1194505A (en) Piperidinol Derivatives and Process for Preparing Them
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
GB1409898A (en) 1,1-dioxidothiazolidin-4-ones and processes for their manufacture
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
GB1424432A (en) Pharmaceutical compositions
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1508338A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SPA Amended specification published
PS Patent sealed [section 19, patents act 1949]
PLE Entries relating assignments, transmissions, licences in the register of patents
PCNP Patent ceased through non-payment of renewal fee